Atypical Chronic Myelogenous Leukemia, BCR-ABL1 Negative: Diagnostic Criteria and Treatment Approaches.
Diamantopoulos PT, Viniou NA.
Front Oncol. 2021 Nov 17;11:722507. doi: 10.3389/fonc.2021.722507. eCollection 2021.
Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review.
Patnaik MM, Lasho T.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):460-464. doi: 10.1182/hematology.2020000163.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Cortes JE, Gambacorti-Passerini C, Deininger MW, Mauro MJ, Chuah C, Kim DW, Dyagil I, Glushko N, Milojkovic D, le Coutre P, Garcia-Gutierrez V, Reilly L, Jeynes-Ellis A, Leip E, Bardy-Bouxin N, Hochhaus A, Brümmendorf TH.
J Clin Oncol. 2018 Jan 20;36(3):231-237. doi: 10.1200/JCO.2017.74.7162. Epub 2017 Nov 1.
Uncommon phenotypes of BCR::ABL1-positive chronic myelogenous leukemia.
Jajosky AN, Lichtman MA.
Haematologica. 2025 Sep 1;110(9):1912-1920. doi: 10.3324/haematol.2025.287792. Epub 2025 May 15.
Myelodysplastic/myeloproliferative neoplasms.
Cazzola M, Malcovati L, Invernizzi R.
Hematology Am Soc Hematol Educ Program. 2011;2011:264-72. doi: 10.1182/asheducation-2011.1.264.
Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia.
Akiyama H, Maruyama T, Uetake T, Kawaguchi K, Sakamaki H, Onozawa Y.
Rev Infect Dis. 1991 Sep-Oct;13(5):815-8. doi: 10.1093/clinids/13.5.815.
Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies.
Kim SY, Song IC, Kim J, Kwon GC.
Ann Diagn Pathol. 2024 Aug;71:152317. doi: 10.1016/j.anndiagpath.2024.152317. Epub 2024 Apr 18.
Atypical Presentation of Chronic Myelogenous Leukemia.
Updyke KM, Morales-Lappot J, Lee T.
Cureus. 2017 May 26;9(5):e1280. doi: 10.7759/cureus.1280.
Clinical features and treatment response to TKIs in chronic myeloid leukemia patients with atypical BCR::ABL1 transcripts.
Wang H, Han C, Gong B, Liu Y, Liu K, Gu R, Wang Y, Wei H, Mi Y, Liu B, Wang J.
Leuk Res. 2025 Aug;155:107733. doi: 10.1016/j.leukres.2025.107733. Epub 2025 Jun 5.
Distinguishing atypical chronic myeloid leukemia from other Philadelphia-negative chronic myeloproliferative neoplasms.
Sadigh S, Hasserjian RP, Hobbs G.
Curr Opin Hematol. 2020 Mar;27(2):122-127. doi: 10.1097/MOH.0000000000000565.
